ZICO Holdings Inc. (SGX:40W)
Singapore · Delayed Price · Currency is SGD 0.0440
0.00 (0.00%)
At close: Jul 23, 2025
Ligand Pharmaceuticals Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -6.59 | -5.57 | -7.28 | -0.26 | 0.29 | -2.44 | Upgrade |
Depreciation & Amortization | 1.33 | 1.36 | 1.45 | 1.55 | 2.67 | 2.23 | Upgrade |
Other Amortization | 0.03 | 0.03 | 0.1 | 0.43 | 0.67 | 0.8 | Upgrade |
Loss (Gain) From Sale of Assets | -0.13 | -0.15 | 0.02 | -0.01 | -1.94 | 0.01 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 0.15 | 0.04 | 0 | 0.08 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | 0.48 | - | - | Upgrade |
Loss (Gain) on Equity Investments | 0.13 | -0.5 | -0.08 | -0.7 | -0.77 | -1.03 | Upgrade |
Stock-Based Compensation | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.05 | Upgrade |
Provision & Write-off of Bad Debts | 2.2 | 2.2 | 2.79 | -0.27 | 1.01 | 1.79 | Upgrade |
Other Operating Activities | 1.49 | 1.21 | 0.34 | -1.13 | 0.98 | 0.25 | Upgrade |
Change in Accounts Receivable | 0.12 | -1.67 | 2.59 | 1.42 | -0.37 | -0.6 | Upgrade |
Change in Accounts Payable | 0.74 | 0.49 | 0.25 | 2.28 | 0.08 | -1.82 | Upgrade |
Change in Other Net Operating Assets | 0.03 | 0.13 | 0.31 | -0.42 | -0.3 | -0.08 | Upgrade |
Operating Cash Flow | -0.62 | -2.45 | 0.66 | 3.44 | 2.33 | -0.76 | Upgrade |
Operating Cash Flow Growth | - | - | -80.88% | 47.87% | - | - | Upgrade |
Capital Expenditures | -0.04 | -0.04 | -0.2 | -0.51 | -0.11 | -0.05 | Upgrade |
Sale of Property, Plant & Equipment | -0 | 0.02 | 0.04 | 0.07 | - | - | Upgrade |
Divestitures | 0.13 | 0.13 | - | - | 2.11 | 0.05 | Upgrade |
Sale (Purchase) of Intangibles | -0 | -0 | -0 | -0.02 | -0.02 | -0.04 | Upgrade |
Investment in Securities | 0.52 | 0.47 | 0.95 | -1.97 | 0.26 | -0.23 | Upgrade |
Other Investing Activities | 0.77 | 0.79 | 0.76 | 2.04 | 1.49 | 0.49 | Upgrade |
Investing Cash Flow | 1.37 | 1.37 | 1.55 | -0.38 | 3.73 | 0.21 | Upgrade |
Long-Term Debt Issued | - | 1 | 0.55 | - | 2 | 2.31 | Upgrade |
Total Debt Issued | 2.05 | 1 | 0.55 | - | 2 | 2.31 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -2.19 | -1.54 | Upgrade |
Long-Term Debt Repaid | - | -3.13 | -3.31 | -4.86 | -3.24 | -1.63 | Upgrade |
Total Debt Repaid | -3.27 | -3.13 | -3.31 | -4.86 | -5.43 | -3.17 | Upgrade |
Net Debt Issued (Repaid) | -1.22 | -2.13 | -2.76 | -4.86 | -3.43 | -0.85 | Upgrade |
Issuance of Common Stock | - | 2.04 | 2.7 | 2.35 | - | - | Upgrade |
Other Financing Activities | -1.21 | -0.91 | -1.77 | -1.15 | -0.9 | -0.69 | Upgrade |
Financing Cash Flow | -2.43 | -1 | -1.83 | -3.65 | -4.32 | -1.54 | Upgrade |
Foreign Exchange Rate Adjustments | 0.05 | 0.04 | -0.08 | 0.19 | -0.04 | 0.02 | Upgrade |
Net Cash Flow | -1.62 | -2.04 | 0.29 | -0.4 | 1.69 | -2.07 | Upgrade |
Free Cash Flow | -0.66 | -2.49 | 0.46 | 2.94 | 2.21 | -0.81 | Upgrade |
Free Cash Flow Growth | - | - | -84.43% | 32.65% | - | - | Upgrade |
Free Cash Flow Margin | -3.94% | -14.42% | 2.66% | 14.77% | 9.91% | -3.83% | Upgrade |
Free Cash Flow Per Share | - | -0.01 | 0.00 | 0.01 | 0.01 | -0.00 | Upgrade |
Cash Interest Paid | 0.72 | 0.72 | 0.86 | 0.87 | 0.57 | 0.69 | Upgrade |
Cash Income Tax Paid | 0.24 | 0.24 | 0.3 | 0.7 | 0.57 | 0.39 | Upgrade |
Levered Free Cash Flow | -0.58 | -0.6 | -1.4 | 0.17 | 2.94 | 6.01 | Upgrade |
Unlevered Free Cash Flow | -0.21 | -0.15 | -0.87 | 0.72 | 3.29 | 6.44 | Upgrade |
Change in Working Capital | 0.89 | -1.05 | 3.15 | 3.29 | -0.6 | -2.5 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.